Gilead Sciences
GILD
#129
Rank
S$194.99 B
Marketcap
S$157.15
Share price
-1.14%
Change (1 day)
28.57%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): S$8.54

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S$8.45. In 2024 the company made an earnings per share (EPS) of S$0.49 a decrease over its 2023 EPS that were of S$5.90.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$8.541632.79%
2024S$0.49-91.65%
2023S$5.9023.98%
2022S$4.76-25.86%
2021S$6.424850%
2020S$0.13-97.64%
2019S$5.500.9%
2018S$5.4518.71%
2017S$4.59-64.88%
2016S$13.07-18.45%
2015S$16.0255.28%
2014S$10.32296.02%
2013S$2.6117.89%
2012S$2.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
S$16.89 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$18.58 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$1.75-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$5.80-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.25 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.23-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.53 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$26.60 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.84 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA